isoniazid has been researched along with Overweight in 2 studies
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guehi, C | 1 |
| Badjé, A | 1 |
| Gabillard, D | 1 |
| Ouattara, E | 1 |
| Koulé, SO | 1 |
| Moh, R | 1 |
| Ekouevi, D | 1 |
| Ahibo, H | 1 |
| N'Takpé, JB | 1 |
| Menan, GK | 1 |
| Deschamps, N | 1 |
| Lecarrou, J | 1 |
| Eholié, S | 1 |
| Anglaret, X | 1 |
| Danel, C | 1 |
| Lloret-Linares, C | 1 |
| Mouly, S | 1 |
| Hoang-Nguyen, DT | 1 |
| Evans, J | 1 |
| Raskine, L | 1 |
| Lopes, A | 1 |
| Cambau, E | 1 |
| Bergmann, JF | 1 |
| Sellier, P | 1 |
1 trial available for isoniazid and Overweight
| Article | Year |
|---|---|
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Body Mass Index; Cote d'Ivoire; Female; HIV Infection | 2016 |
1 other study available for isoniazid and Overweight
| Article | Year |
|---|---|
Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans; | 2013 |